机译:在先天性素细胞痣综合征和多个,NRAS NRAS NRAS和BRAF BRAF BRAF突变阴性结节的侵略性的黑色素瘤
Department of DermatologyOslo University HospitalOslo Norway;
Department of Plastic and Reconstructive SurgeryOslo University HospitalOslo Norway;
Paediatric Dermatology DepartmentGreat Ormond Street HospitalLondon UK;
Department of Neonatal Intensive CareOslo University HospitalOslo Norway;
Faculty of MedicineUniversity of OsloOslo Norway;
Unit for Pediatric RadiologyOslo University HospitalOslo Norway;
Department of PathologyOslo University HospitalOslo Norway;
Faculty of MedicineUniversity of OsloOslo Norway;
Department of Dermatology Neurology and RheumatologyUniversity Hospital of North NorwayTroms;
Faculty of MedicineUniversity of OsloOslo Norway;
neoplasms‐malignant; nevi‐melanocytic;
机译:在先天性素细胞痣综合征和多个,NRAS NRAS NRAS和BRAF BRAF BRAF突变阴性结节的侵略性的黑色素瘤
机译:β-catenin,LEF-1和HPA-1的水平升高与BRAF外显子11和15以及NRAS外显子1和2阴性的BRAF和NRAS突变的急性黑色素瘤的预后不良相关。
机译:BRAF / NRAS BRAF / NRAS并发突变在临床基基转移性黑色素瘤队列中的临床意义
机译:肿瘤细胞作为质量保证(QA)测量,用于黑色瘤中BRAF突变的准确临床检测
机译:原发性皮肤黑素瘤中的NRAS和BRAF突变:单个肿瘤在径向和垂直生长期之间的突变率比较。
机译:β-cateninLEF-1和HPA-1的水平升高与BRAF外显子11和15以及NRAS外显子1和2阴性的BRAF和NRAS突变的急性黑色素瘤的预后不良相关。
机译:β-catenin,lef-1和HPA-1水平的水平与腺黑色素瘤的预后不良,具有阴性BRAF和BRAF外显子11和15和NRAS外显子1和2的NRAS突变